Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 2 May 22 EFFECT Notice of effectiveness
- 25 Apr 22 POS AM Prospectus update (post-effective amendment)
- 2 Sep 21 POS EX Additional exhibits for listing
- 11 May 21 EFFECT Notice of effectiveness
- 5 May 21 POS AM Prospectus update (post-effective amendment)
- 5 Feb 21 424B5 Prospectus supplement for primary offering
- 3 Feb 21 424B5 Prospectus supplement for primary offering
- 17 Aug 20 EFFECT Notice of effectiveness
-
4 Aug 20 S-3 Shelf registration
KLDO similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form S-3 of our report dated March 2, 2020 relating to the financial statements of Kaleido Biosciences, Inc., appearing in the Annual Report on Form 10-K of Kaleido Biosciences, Inc. for the year ended December 31, 2019. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
August 4, 2020